✦ LIBER ✦

28 PILOT STUDY OF SIROLIMUS IN CIRRHOTIC PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA

✍ Scribed by T. Decaens; A. Luciani; E. Itti; A. Hulin; M. Hurtova; A. Laurent; D. Cherqui; A. Mallat; C. Duvoux

Book ID: 117375954
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 59 KB
Volume: 48
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(08)60030-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

369 PHARMACOKINETIC STUDY OF SIROLIMUS I

369 PHARMACOKINETIC STUDY OF SIROLIMUS IN CIRRHOTIC PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA

✍ T. Decaens; A. Hulin; M. Hurtova; A. Luciani; E. Itti; A. Laurent; D. Cherqui; A 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Phase II study of sirolimus in treatment

Phase II study of sirolimus in treatment-naive patients with advanced hepatocellular carcinoma

✍ Thomas Decaens; Alain Luciani; Emmanuel Itti; Anne Hulin; Françoise Roudot-Thora 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 668 KB

Effects of the combined treatment with t

Effects of the combined treatment with thalidomide, megestrol and interleukine-2 in cirrhotic patients with advanced hepatocellular carcinoma: A pilot study

✍ F. Mirici Cappa; M.C. Cantarini; G. Magini; A. Zambruni; C. Bendini; V. Santi; M 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 125 KB

209 FIBROSIS PROGRESSION DURING SUNITINI

209 FIBROSIS PROGRESSION DURING SUNITINIB THERAPY IN CIRRHOTIC PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA

✍ M. Biolato; M. Basso; A. Forgione; S. Racco; L. Miele; M. Pompili; G.L. Rapaccin 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Phase II study of gemcitabine in patient

Phase II study of gemcitabine in patients with advanced hepatocellular carcinoma

✍ Tai-Shen Yang; Yung-Chang Lin; Jen-Shi Chen; Hung-Ming Wang; Chen-Hsu Wang 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB 👁 3 views

Phase 2 study of cetuximab in patients w

Phase 2 study of cetuximab in patients with advanced hepatocellular carcinoma

✍ Andrew X. Zhu; Keith Stuart; Lawrence S. Blaszkowsky; Alona Muzikansky; Donald P 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB 👁 1 views

## Abstract ## BACKGROUND. Epidermal growth factor receptor (EGFR) and ligand expression is frequently seen in hepatocellular carcinoma (HCC). A phase 2 study was performed with cetuximab, a chimeric monoclonal antibody that binds specifically to EGFR, in patients with advanced HCC. ## METHODS.